Athersys, Inc , a cell therapy and regenerative medicine company developing MultiStem for critical care indications, announced that the United States Patent and Trademark Office...
Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with over US$80Million. Current round of financing was led by...
The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced the acceleration of plans to build capacity to manufacture more than...
BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced an...
